Commission Delegated Regulation (EU) 2020/1431 of 14 July 2020 amending Regulation (EU) No 658/2014 of the European Parliament and of the Council as regards the adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
Commission Delegated Regulation (EU) 2020/1431of 14 July 2020amending Regulation (EU) No 658/2014 of the European Parliament and of the Council as regards the adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 658/2014 of the European Parliament and of the Council of 15 May 2014 on fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human useOJ L 189, 27.6.2014, p. 112., and in particular Article 15(6) thereof,Whereas:(1)In accordance with Article 67(3) of Regulation (EC) No 726/2004 of the European Parliament and of the CouncilRegulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ L 136, 30.4.2004, p. 1)., the revenue of the European Medicines Agency includes fees paid by undertakings for obtaining and maintaining Union marketing authorisations and for other services provided by the Agency, and for services provided by the coordination group as regards the fulfilment of its tasks in accordance with Articles 107c, 107e, 107g, 107k and 107q of Directive 2001/83/EC of the European Parliament and of the CouncilDirective 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67)..(2)The last adjustment of the fees and remuneration amounts laid down in Regulation (EU) No 658/2014 was carried out in 2018 based on the inflation rate of 2017. The inflation rate of the Union for the years 2018 and 2019, as published by the Statistical Office of the European Union, was respectively 1,7 % and 1,6 %. Taking into consideration the level of the inflation rates for those years, it is considered justified to adjust, in accordance with Article 15(6) of Regulation (EU) No 658/2014, the amounts of the fees and the amounts of the remuneration for rapporteurs and co-rapporteurs referred to in Parts I to IV of the Annex of that Regulation. A cumulative adjustment taking into account the inflation rates for both 2018 and 2019 should therefore be applied.(3)For the sake of simplicity, the adjusted amounts should be rounded to the nearest EUR 10, with the exception of the annual fee for information technology systems and literature monitoring where the adjusted level should be rounded to the nearest EUR 1.(4)Fees laid down in Regulation (EU) No 658/2014 are due either at the date of the start of the respective procedure or, in the case of the annual fee for information technology systems and literature monitoring, on 1 July of every year. Consequently, the applicable amount will be determined by the due date of the fee and there is no need to set specific transitional provisions for pending procedures.(5)Regulation (EU) No 658/2014 should therefore be amended accordingly,HAS ADOPTED THIS REGULATION:
Article 1The Annex to Regulation (EU) No 658/2014 is amended as follows:(1)in Part I, point 1 is amended as follows:(a)"EUR 20110" is replaced by "EUR 20780";(b)"EUR 13520" is replaced by 13970’;(2)in Part II, point 1 is amended as follows:(a)in the introductory sentence, "EUR 44340" is replaced by "EUR 45810";(b)point (a) is amended as follows:(i)"EUR 17740" is replaced by "EUR 18330";(ii)"EUR 7510" is replaced by "EUR 7760";(c)point (b) is amended as follows:(i)"EUR 26600" is replaced by "EUR 27480";(ii)"EUR 11260" is replaced by "11630";(3)in Part III, point 1 is amended as follows:(a)the first subparagraph is amended as follows:(i)"EUR 184600" is replaced by "EUR 190740";(ii)"EUR 40020" is replaced by "EUR 41350";(iii)"EUR 304660" is replaced by "EUR 314790";(b)the second subparagraph is amended as follows:(i)in point (a), "EUR 123060" is replaced by "EUR 127150";(ii)in point (b), "EUR 149740" is replaced by "EUR 154730";(iii)in point (c), "EUR 176420" is replaced by "EUR 182290";(iv)in point (d), "EUR 203090" is replaced by "EUR 209840";(c)in the fourth subparagraph, point (b) is amended as follows:(i)"EUR 1030" is replaced by "EUR 1070";(ii)"EUR 2050" is replaced by "EUR 2110";(iii)"EUR 3100" is replaced by "EUR 3200";(4)in point 1 of Part IV, "EUR 69" is replaced by "EUR 71".
Article 2This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. It shall apply from 1 November 2020.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 14 July 2020.For the CommissionThe PresidentUrsula von der Leyen